Recent Quarter Total Invested
$375.62 M
Recent Quarter Institutional Ownership Percentage
94.8%
Total Invested of Last Quarter
$229.55 M
Ownership Percentage of Last Quarter
94.05%
Mersana Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | 11/14/2024 | 19.36 M | $36.60 M | 0.00% | 15.82% |
| NEXTECH INVEST LTD. | 11/14/2024 | 12.07 M | $22.81 M | 26.68% | 9.86% |
| VR ADVISER, LLC | 11/14/2024 | 11.33 M | $21.41 M | 0.00% | 9.25% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2024 | 8.66 M | $16.37 M | 0.00% | 7.08% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 8.62 M | $16.30 M | 100.00% | 7.04% |
| CITADEL ADVISORS LLC | 11/14/2024 | 4.41 M | $8.34 M | 60.79% | 3.60% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 3.05 M | $5.76 M | 0.00% | 2.49% |
| STATE STREET CORP | 11/14/2024 | 2.73 M | $5.15 M | 1.62% | 2.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.41 M | $4.56 M | -3.22% | 1.97% |
| JPMORGAN CHASE & CO | 11/08/2024 | 2.35 M | $4.44 M | 18.94% | 1.92% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 2.22 M | $4.20 M | -25.32% | 1.82% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.96 M | $3.70 M | 57.38% | 1.60% |
| BOXER CAPITAL, LLC | 11/14/2024 | 1.82 M | $3.43 M | 100.00% | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.59 M | $3.00 M | -36.58% | 1.30% |
| MORGAN STANLEY | 11/14/2024 | 1.36 M | $2.58 M | -39.97% | 1.11% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2024 | 1.31 M | $2.47 M | 0.00% | 1.07% |
| VERITION FUND MANAGEMENT LLC | 11/14/2024 | 1.30 M | $2.46 M | 11,695.18% | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 11/14/2024 | 1.20 M | $2.27 M | -27.84% | 0.98% |
| EXOME ASSET MANAGEMENT LLC | 11/14/2024 | 1.18 M | $2.23 M | 100.00% | 0.96% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 1.09 M | $2.05 M | 0.00% | 0.89% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 1.02 M | $1.93 M | -30.24% | 0.84% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 993,046 | $1.88 M | 104.50% | 0.81% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 992,000 | $1.87 M | 0.00% | 0.81% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 990,036 | $1.87 M | 519.65% | 0.81% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 877,043 | $1.66 M | -11.64% | 0.72% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 618,305 | $1.17 M | 16.03% | 0.51% |
| UBS OCONNOR LLC | 11/14/2024 | 570,029 | $1.08 M | 4.73% | 0.47% |
| HEALTHINVEST PARTNERS AB | 11/12/2024 | 538,621 | $1.02 M | 191.30% | 0.44% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 535,819 | $1.01 M | 100.00% | 0.44% |
| CLARIVEST ASSET MANAGEMENT LLC | 11/12/2024 | 500,498 | $1.01 M | 0.00% | 0.41% |
| BARCLAYS PLC | 11/19/2024 | 494,516 | $934,000 | 32.68% | 0.40% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 492,719 | $931,239 | -65.98% | 0.40% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 486,800 | $920,052 | -32.32% | 0.40% |
| UBS GROUP AG | 11/14/2024 | 473,527 | $894,966 | 1,253.59% | 0.39% |
| WOODLINE PARTNERS LP | 11/14/2024 | 433,552 | $819,413 | -70.45% | 0.35% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 372,173 | $703,407 | -17.81% | 0.30% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2024 | 364,727 | $689,334 | 100.00% | 0.30% |
| XTX TOPCO LTD | 11/14/2024 | 347,255 | $656,312 | 185.97% | 0.28% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 312,623 | $590,857 | 0.00% | 0.26% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 300,222 | $567,420 | -59.90% | 0.25% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 271,774 | $514,000 | 368.90% | 0.22% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 259,783 | $490,990 | -62.45% | 0.21% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 233,209 | $440,765 | -1.28% | 0.19% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 11/04/2024 | 189,660 | $358,457 | 8.12% | 0.15% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 186,060 | $351,653 | 0.00% | 0.15% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 182,793 | $345,479 | 100.00% | 0.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 168,300 | $318,087 | 100.00% | 0.14% |
| RHUMBLINE ADVISERS | 11/12/2024 | 166,846 | $315,328 | -5.24% | 0.14% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 151,201 | $285,770 | 22.59% | 0.12% |
| MACQUARIE GROUP LTD | 11/14/2024 | 150,000 | $284,000 | 0.00% | 0.12% |
Mersana Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of MRSN shares?
During the previous two years, 139 institutional investors and hedge funds held shares of Mersana Therapeutics, Inc.. The most heavily invested institutionals were:
EcoR1 Capital, LLC: 19.36 M
Nextech Invest Ltd.: 12.07 M
VR Adviser, LLC: 11.33 M
Bain Capital Life Sciences Investors, LLC: 8.66 M
BlackRock Funding, Inc. /DE: 8.62 M
CITADEL ADVISORS LLC: 4.41 M
-
What percentage of Mersana Therapeutics, Inc. stock is owned by institutional investors?
94.80% of Mersana Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at MRSN ?
Institutional investors have bought a total of 120.12 M shares in the last 24 months. This purchase volume represents approximately $245.04 M in transactions.